Direct Thrombin Inhibitor [EPC]

974 reported adverse events

Drugs of this class: ARGATROBAN

These side effects are most commonly reported by patients taking drugs of the Direct Thrombin Inhibitor [EPC] class:

# Side effect Count
0 HEPARIN-INDUCED THROMBOCYTOPENIA 106
1 INTERNATIONAL NORMALISED RATIO INCREASED 106
2 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 82
3 COAGULATION TIME PROLONGED 64
4 HAEMORRHAGE 61
5 CEREBRAL INFARCTION 48
6 PULMONARY EMBOLISM 46
7 DEEP VEIN THROMBOSIS 43
8 THROMBOCYTOPENIA 41
9 THROMBOSIS 40
See all common reactions for Direct Thrombin Inhibitor [EPC]

Drugs of the Direct Thrombin Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 GRANULICATELLA BACTERAEMIA 1 0.2500
1 BURKITT'S LYMPHOMA STAGE IV 1 0.2500
2 OESOPHAGEAL INTRAMURAL HAEMATOMA 7 0.2333
3 FAECAL CALPROTECTIN DECREASED 1 0.1250
4 BILE OUTPUT 1 0.1250
5 GASTRIC LAVAGE ABNORMAL 1 0.0588
6 COAGULATION TIME PROLONGED 64 0.0586
7 ACTIVATED PARTIAL THROMBOPLASTIN TIME ABNORMAL 8 0.0442
8 CARDIOPULMONARY BYPASS 1 0.0435
9 COAGULATION TIME ABNORMAL 9 0.0393
See all enriched reactions for Direct Thrombin Inhibitor [EPC]